These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32310188)

  • 21. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
    Lichter DG; Benedict RHB; Hershey LA
    J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.
    Darweesh SKL; Wolters FJ; Postuma RB; Stricker BH; Hofman A; Koudstaal PJ; Ikram MK; Ikram MA
    JAMA Neurol; 2017 Dec; 74(12):1431-1438. PubMed ID: 28973176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep spindles in Parkinson's disease may predict the development of dementia.
    Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
    Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.
    Yoo HS; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee PH
    J Neurol; 2019 Jul; 266(7):1601-1610. PubMed ID: 31011798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predict cognitive decline with clinical markers in Parkinson's disease (PRECODE-1).
    Wilson H; Pagano G; Yousaf T; Polychronis S; De Micco R; Giordano B; Niccolini F; Politis M
    J Neural Transm (Vienna); 2020 Jan; 127(1):51-59. PubMed ID: 31853652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study.
    Tang Y; Liang X; Han L; Peng F; Shen B; Yu H; Shen Y; Shen C; Yu J; Wang J
    J Parkinsons Dis; 2020; 10(3):1209-1216. PubMed ID: 32568115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher vitamin B12 level at Parkinson's disease diagnosis is associated with lower risk of future dementia.
    McCarter SJ; Stang C; Turcano P; Mielke MM; Ali F; Bower JH; Savica R
    Parkinsonism Relat Disord; 2020 Apr; 73():19-22. PubMed ID: 32203914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
    Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
    PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
    Domellöf ME; Ekman U; Forsgren L; Elgh E
    Acta Neurol Scand; 2015 Aug; 132(2):79-88. PubMed ID: 25644230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
    Ozdilek B; Kenangil G
    Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
    Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
    Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
    Alty JE; Cosgrove J; Jamieson S; Smith SL; Possin KL
    Clin Neurol Neurosurg; 2015 Dec; 139():244-6. PubMed ID: 26519897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in cognitive profiles between Lewy body and Parkinson's disease dementia.
    Martini A; Weis L; Schifano R; Pistonesi F; Fiorenzato E; Antonini A; Biundo R
    J Neural Transm (Vienna); 2020 Mar; 127(3):323-330. PubMed ID: 31898759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
    Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dementia and mild cognitive impairment in Parkinson's disease: a review].
    Bocanegra Y; Trujillo-Orrego N; Pineda D
    Rev Neurol; 2014 Dec; 59(12):555-69. PubMed ID: 25501454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's disease and dementia: a longitudinal study (DEMPARK).
    Balzer-Geldsetzer M; Costa AS; Kronenbürger M; Schulz JB; Röske S; Spottke A; Wüllner U; Klockgether T; Storch A; Schneider C; Riedel O; Wittchen HU; Seifried C; Hilker R; Schmidt N; Witt K; Deuschl G; Mollenhauer B; Trenkwalder C; Liepelt-Scarfone I; Gräber-Sultan S; Berg D; Gasser T; Kalbe E; Bodden M; Oertel WH; Dodel R
    Neuroepidemiology; 2011; 37(3-4):168-76. PubMed ID: 22067139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.
    Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Pascual-Sedano B; Campolongo A; Kulisevsky J
    Mov Disord; 2013 Sep; 28(10):1376-83. PubMed ID: 23873810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.